Task: Answer Verification
Input (English): Question: Is the systemic exposure to inhaled beclometasone/formoterol pMDI with valved holding chamber independent of age and body size?
Answer: The systemic exposure to the active ingredients of a fixed dose combination of beclometasone/formoterol administered via pMDI with AeroChamber Plus™ correlates with the nominal dose independently of patient age and body size. Thus, dose reduction in relation to age when using a pMDI with VHC may be unnecessary for reducing the systemic exposure in children.
Output (English): yes